Cognitive and Behavioral Profiles of Children with Aspartylglucosaminuria: A Case Series

被引:0
作者
Crowe, Louise M. [1 ,2 ,3 ]
Brown, Amy [1 ]
Peters, Heidi [4 ]
机构
[1] Royal Childrens Hosp, Murdoch Childrens Res Inst, Dept Clin Sci, Melbourne, Vic, Australia
[2] Royal Childrens Hosp, Dept Psychol, Melbourne, Vic, Australia
[3] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic, Australia
[4] Royal Childrens Hosp, Dept Metab Med, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
aspartylglucosaminuria; lysosomal storage disorder; cognition; children; behavior; FOLLOW-UP; ASPARTYLGLYCOSAMINURIA; TRANSPLANTATION;
D O I
10.1055/s-0041-1730964
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Aspartylglucosaminuria (AGU) is a rare lysosomal storage disorder with an autosomal recessive inheritance. It affects the aspartylglucosaminidase (AGA) gene and causes a deficiency in activity of the enzyme N-aspartyl-beta-glucosaminidase with resultant accumulation of glycoasparagines in body tissues. Children with AGU present with developmental delays in cognitive and language skills. Currently, information on cognition and behavior of children with AGU is limited. This case series presents the neuropsychological and behavioral profiles of three children with AGU assessed at two time points. All the three children had full-scale intelligence quotient ( IQ) scores in the intellectual disabled range (< 70). IQ had declined since their previous cognitive assessment 1 to 2 years prior. Other cognitive skills were significantly below expected levels. Parents reported several behavioral problems and adaptive difficulties. The findings challenge current beliefs that cognition is impaired but stable in children with declines seen in a short time.
引用
收藏
页码:198 / 201
页数:4
相关论文
共 17 条
  • [1] FOLLOW-UP IN PATIENTS WITH ASPARTYLGLUCOSAMINURIA .1. THE COURSE OF INTELLECTUAL FUNCTIONS
    ARVIO, M
    [J]. ACTA PAEDIATRICA, 1993, 82 (05) : 469 - 471
  • [2] FOLLOW-UP IN PATIENTS WITH ASPARTYLGLUCOSAMINURIA .2. ADAPTIVE SKILLS
    ARVIO, M
    [J]. ACTA PAEDIATRICA, 1993, 82 (6-7) : 590 - 594
  • [3] Bone marrow transplantation for aspartylglucosaminuria: Follow-up study of transplanted and non-transplanted patients
    Arvio, M
    Sauna-aho, O
    Peippo, M
    [J]. JOURNAL OF PEDIATRICS, 2001, 138 (02) : 288 - 290
  • [4] Aspartylglycosaminuria: a review
    Arvio, Maria
    Mononen, Ilkka
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2016, 11 : 1 - 10
  • [5] Progressive nature of aspartylglucosaminuria
    Arvio, P
    Arvio, M
    [J]. ACTA PAEDIATRICA, 2002, 91 (03) : 255 - 257
  • [6] Autio S, 1972, J Ment Defic Res, V1, P1
  • [7] Identification of Small Molecule Compounds for Pharmacological Chaperone Therapy of Aspartylglucosaminuria
    Banning, Antje
    Guelec, Christina
    Rouvinen, Juha
    Gray, Steven J.
    Tikkanen, Ritva
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [8] Inborn error metabolic screening in individuals with nonsyndromic autism spectrum disorders
    Campistol, Jaume
    Diez-Juan, Maria
    Callejon, Laura
    Fernandez-De Miguel, Aroa
    Casado, Mercedes
    Garcia Cazorla, Angels
    Lozano, Reymundo
    Artuch, Rafael
    [J]. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2016, 58 (08) : 842 - 847
  • [9] Detailed profile of cognitive dysfunction in children with aspartylglucosaminuria
    Harjunen, Elina Leena
    Laine, Minna
    Tikkanen, Ritva
    Helenius, Paivi
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (02) : 318 - 325
  • [10] Harrison P., 2003, Adaptive Behavior Assessment System-II